CAPTRUST Financial Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,066	Closed	-$168K	–	3679
2022 Q2	$168K	Buy	6,066 +4,400	+264%	+$125K	﹤0.01%	1822
2022 Q1	$56K	Buy	1,666 +1,500	+904%	+$52K	﹤0.01%	2706
2021 Q4	$7K	Buy	166 +66	+66%	+$2.94K	﹤0.01%	3924
2021 Q3	$5K	Hold	100	–	–	﹤0.01%	3959
2021 Q2	$5K	Sell	100 -452	-82%	-$21.7K	﹤0.01%	3876
2021 Q1	$28K	Hold	552	–	–	﹤0.01%	2797
2020 Q4	$28K	Hold	552	–	–	﹤0.01%	2101
2020 Q3	$23K	Buy	552 +100	+22%	+$4.12K	﹤0.01%	1912
2020 Q2	$19K	Buy	+452	New	+$17.8K	﹤0.01%	1962

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

ASB Consultores Aventura, Florida $30.1M AUM 22.96% 1-Year Est. Return

CAPTRUST Financial Advisors's SBIO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2022, closing a stake of 6,066 shares — an estimated $168K sold.

CAPTRUST Financial Advisors first reported a position in SBIO in Q2 2020 and held it in 9 quarters. The position peaked at $168K in Q2 2022. 44 funds tracked by Wall St. Rank hold SBIO as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 6,066 ALPS Medical Breakthroughs ETF shares in Q3 2022, an estimated $168K.
CAPTRUST Financial Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q2 2020 and held it in 9 quarters.
CAPTRUST Financial Advisors's ALPS Medical Breakthroughs ETF position peaked at $168K in Q2 2022.
44 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.